KPMA executives oppose reference price system

The minimum reference price system is expected to force many patients to give up being treated due to the high costs of original drugs, while local pharmaceutical companies have been developing a variety of generic drugs as patients want cheaper medication, according to the Korea Pharmaceutical Manufacturers Association.

In a recent meeting with the Korea Development Institute’s president Hy...